Abstract:<span><h3>Background</h3><p>Patients with atrial high-rate episodes (AHREs) are at higher risk of thromboembolic events and mortality. The risk of major adverse cardiovascular events (MACE) in these patients is unknown.</p></span><span><h3>Objective</h3><p>To investigate the risk of MACE in patients implanted with cardiac implantable electronic devices (CIEDs) developing AHREs</p></span><span><h3>Methods and results</h3><p>We included 852 consecutive patients undergoing CIEDs implantation. Primary outcome was a composite endpoint of MACEs occurring after AHREs ≥ 5 min. AHRE was defined as > 175 bpm and lasting ≥ 5 min. We also performed a subgroup analysis in patients with the longest AHRE lasting ≥ 24 h. Cox regression analysis with time-dependent covariates was used to investigate the relationship between AHREs and MACEs.</p><p>Mean age was 70.0 ± 13.6 years, and 39.3% were women: 325 patients developed AHREs ≥ 5 min [incidence rate (IR) 13.1% year 95% confidence interval (CI) 11.7–14.6] and 124 patients developed AHREs ≥ 24 h (IR 3.7%/year 95% CI 3.1–4.5). During a median follow-up of 37.0 months (IQR 19.0–64.3, 316,132 patient-years), 152 MACEs occurred (IR 4.85%/year, 95% CI 4.11–5.68). The IR of MACE occurring after AHREs onset was higher in patients developing AHREs ≥ 24 h (IR 1.13%/year) than AHREs ≥ 5 min (IR 0.63%/year, <em>p</em> = 0.030).</p><p>Multivariable Cox regression analysis showed that AHREs ≥ 5 min (HR 1.788, 95% CI 1.247–2.562, <em>p</em> = 0.002), diabetes (HR 1.909, 95% CI 1.358–2.683, <em>p</em> p p = 0.001) were associated to MACE. This association was even stronger for AHREs ≥ 24 h (HR 2.390, 95% CI 1.481–3.857, <em>p</em> </p></span><span><h3>Conclusions</h3><p>Patients implanted with CIEDs developing AHREs show a significant risk for MACE, which is dependent on AHREs burden. Cardiovascular prevention strategies in this patient population are warranted.</p></span><span><h3>Graphic abstract</h3></span>

Atrial High-Rate Event Incidence and Predictors in Patients With Permanent Pacemaker Implantation

The incidence and risk factors of atrial high-rate episodes in patients with a dual-chamber pacemaker

Clinical evaluation of pacemaker automatic capture management and atrioventricular interval extension algorithm.

New-onset Heart Failure after Permanent Right Ventricular Apical Pacing in Patients with Acquired High-Grade Atrioventricular Block and Normal Left Ventricular Function.

The Risk Factors of New-Onset Atrial Fibrillation after Pacemaker Implantation

Progression of Device-Detected Atrial High-Rate Episodes and the Risk of All-Cause Mortality

A retrospective study of atrial fibrillation after DDD pacemaker implantation

Atrial Fibrillation Burden Detected by Dual-Chamber Pacemakers As a Predictor for Cardiac Outcomes: A Retrospective Single-Center Cohort Study.

ANALYSIS OF PREDICTORS OF ATRIAL FIBRILLATION AFTER PACEMAKER IMPLANTATION

High-Sensitivity C-Reactive Protein is a Predictor of Subsequent Atrial High-Rate Episodes in Patients with Pacemakers and Preserved Ejection Fraction

Association of device-detected atrial high-rate episodes with long-term cardiovascular and all-cause mortality: a cohort study

Initial heart rate score predicts new-onset atrial tachyarrhythmias in pacemaker patients

Long-term Risk of Recurrent Atrial Fibrillation As Documented by an Implantable Monitoring Device: Implications for Optimal Patient Care.

Incidence and Predictors of Permanent Pacemaker Implantation in Patients Who Underwent Transcatheter Aortic Valve Replacement: Observation of a Chinese Population.

Occurrence Of Persistent Atrial Fibrillation During Pacing For Sinus Node Disease: The Influence Of His Bundle Pacing Versus Managed Ventricular Pacing

Atrial Dyssynchrony: A New Predictor for Atrial High-Rate Episodes in Patients with Cardiac Resynchronization Therapy.

Atrial Dysfunction and Interatrial Dyssynchrony Predict Atrial High Rate Episodes: Insight into the Distinct Effects of Right Atrial Appendage Pacing

Correlation analysis of risk factors of atrial fibrillation after artificial cardiac pacemaker implantation

Predicting factors of heart arrhythmia in patients with permanent heart pacemaker

Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices

Risk of Malignant Ventricular Arrhythmias in Patients with Mild to Moderately Reduced Ejection Fraction Following Permanent Pacemaker Implantation